T38.812 Poisoning by anterior pituitary [adenohypophyseal] hormones, intentional self-harm

Name of the Condition

• Poisoning by anterior pituitary [adenohypophyseal] hormones, intentional self-harm

Summary

This condition describes intentional self-harm resulting from exposure to anterior pituitary hormones or their synthetic substitutes. It applies when the specific hormone or agent is not identified, and the event is classified as intentional. The code captures adverse effects or toxic reactions from these substances in a self-harm context.

Causes

The causes involve intentional exposure to anterior pituitary hormones or synthetic substitutes, which may occur through deliberate ingestion, administration, or contact. These exposures can stem from intentional misuse of medications, self-inflicted harm, or intentional consumption of substances containing hormonal agents.

Risk Factors

• History of intentional self-harm or suicidal behavior
• Access to anterior pituitary hormone therapies or supplements
• Mental health conditions (e.g., depression, anxiety) affecting judgment
• Substance use disorders involving hormonal agents
• Social or environmental stressors contributing to self-harm

Symptoms

Symptoms depend on the specific hormone involved but may include metabolic disturbances (e.g., hyper- or hypoglycemia), endocrine imbalances, or organ-specific effects. Adverse reactions could manifest as hyper- or hypofunction of target systems, while poisoning may lead to acute toxicity or organ damage.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, history of intentional exposure, and laboratory tests to identify hormone levels or toxic substances. Healthcare providers assess the context of self-harm, review medication history, and rule out other causes. Imaging or additional tests may be used to evaluate organ function or complications.

Treatment Options

Treatment focuses on stabilizing the patient, managing acute symptoms, and addressing the underlying self-harm behavior. This may include supportive care, antidotes (if available), or interventions to correct metabolic imbalances. Mental health support and safety planning are critical components of care.

Prognosis and Follow-Up

Prognosis depends on the severity of exposure, timely intervention, and underlying mental health status. Follow-up care involves monitoring for complications, addressing mental health needs, and ensuring adherence to safety plans. Long-term outcomes vary based on the extent of physical harm and access to mental health resources.

Complications

Complications may include organ damage (e.g., renal, hepatic), metabolic crises, or persistent endocrine dysfunction. Severe cases can lead to life-threatening conditions requiring intensive care. Psychological complications, such as ongoing suicidal ideation, may also occur.

Lifestyle & Prevention

Prevention strategies include secure storage of hormonal medications, education on safe use, and addressing mental health concerns. Support systems and crisis intervention resources can reduce the risk of intentional self-harm. Regular mental health check-ins and medication management are important for at-risk individuals.

When to Seek Professional Help

Seek immediate medical attention if intentional exposure to anterior pituitary hormones occurs, or if symptoms of poisoning (e.g., severe metabolic changes, organ dysfunction) develop. Mental health professionals should be consulted for ongoing support and safety planning.

Tips for Medical Coders

Document the intent (intentional self-harm) and context of exposure clearly. Ensure the code aligns with clinical findings and the absence of a more specific hormone or agent. Verify that the event is classified as intentional self-harm and not accidental or therapeutic.